All Stories

  1. Diagnosis and outcomes of fever of unknown origin cases with an erythrocyte sedimentation rate of 100 mm/h or more: An International ID-IRI (Infectious Diseases – International Research Initiative) Observational Retrospective Cohort Study
  2. Managing Candida auris fungemias: the results of a prospective and international study
  3. Mortality Associated with Surgical Site Infections Following Cardiac Surgery: Insights from the International ID-IRI Study
  4. Profiles of primary brain abscesses and their impact on survival: An international ID-IRI study
  5. Impact of the COVID-19 pandemic on antibiotic utilization in a tertiary hospital
  6. Identifying risk factors for blood culture negative infective endocarditis: An international ID-IRI study
  7. Factors affecting mortality in COVID-19-associated pulmonary aspergillosis: An international ID-IRI study
  8. The Predictors of COVID-19 Immunogenicity Elicited by Vaccines Against SARS-CoV-2 in Stem Cell Transplant Recipients
  9. Factors influencing mortality in COVID-19-associated mucormycosis: The international ID-IRI study
  10. Blood Culture Negative Endocarditis; What Do Concurrent Cardiac Disorders Tell Us?
  11. Infectious causes of fever of unknown origin in developing countries: An international ID-IRI study
  12. Understanding clinical outcomes and factors influencing mortality in intensive care unit patients with COVID‐19‐associated candidemia
  13. Can daily bathing with 4% chlorhexidine + daily chlorhexidine wipe for 1 week be effective in decolonizing Candida auris colonization?
  14. Prospective analysis of febrile neutropenia patients with bacteraemia: the results of an international ID–IRI study
  15. Changing Trends in the Epidemiology of Delta Virus Infection
  16. Clinicopathological profile of peritoneal tuberculosis and a new scoring model for predicting mortality: an international ID-IRI study
  17. Features of Mpox infection: The analysis of the data submitted to the ID-IRI network
  18. The earthquake in Türkiye and infectious disease concerns
  19. Predictive factors and prognostic value of candiduria in critically-ill patients with solid and hematological malignancies
  20. Classical fever of unknown origin in 21 countries with different economic development: an international ID-IRI study
  21. Analyzing central-line associated bloodstream infection prevention bundles in 22 countries: The results of ID-IRI survey
  22. Self-reported antibiotic stewardship and infection control measures from 57 intensive care units: An international ID-IRI survey
  23. Factors leading to dissemination of cutaneous anthrax: an international ID-IRI study
  24. Vaccine hesitancy and refusal among parents: An international ID-IRI survey
  25. Survival in rhino-orbito-cerebral mucormycosis: An international, multicenter ID-IRI study
  26. Vector-borne and zoonotic infections and their relationships with regional and socioeconomic statuses: An ID-IRI survey in 24 countries of Europe, Africa and Asia
  27. International Multicentre Study of Candida auris Infections
  28. Profiles of multidrug-resistant organisms among patients with bacteremia in intensive care units: an international ID-IRI survey
  29. Managing adult patients with infectious diseases in emergency departments: international ID-IRI study
  30. Letter to Editor in response to Dr. Gupta
  31. Brucellosis in Patients with Neoplasm; A Research Article
  32. Healthcare worker infections and deaths due to COVID-19: A survey from 37 nations and a call for WHO to post national data on their website
  33. Anxiety among front-line health-care workers supporting patients with COVID-19: A global survey
  34. The diagnostic utility of the “Thwaites’ system” and “lancet consensus scoring system” in tuberculous vs. non-tuberculous subacute and chronic meningitis: multicenter analysis of 395 adult patients
  35. Antibiotic use in patients with COVID-19: a ‘snapshot’ Infectious Diseases International Research Initiative (ID-IRI) survey
  36. A Statistical Modeling of the Course of COVID-19 (SARS-CoV-2) Outbreak: A Comparative Analysis
  37. Various combinations of Carbapenemase production in community-acquired clinical isolates in Nepal
  38. Prediction of unfavorable outcomes in West Nile virus neuroinvasive infection – Result of a multinational ID-IRI study
  39. A novel id-iri score: development and internal validation of the multivariable community acquired sepsis clinical risk prediction model
  40. Clinicopathological profile of gastrointestinal tuberculosis: a multinational ID-IRI study
  41. Detection of Pan drug resistance OXA-48 producing Providencia in an ICU patient for the first time in Nepal
  42. International Nosocomial Infection Control Consortium (INICC) report, data summary of 45 countries for 2012-2017: Device-associated module
  43. Treatment of ventilator-associated pneumonia (VAP) caused by Acinetobacter: results of prospective and multicenter ID-IRI study
  44. Portraying infective endocarditis: results of multinational ID-IRI study
  45. Brucellosis in pregnancy: results of multicenter ID-IRI study
  46. Perceived differences between intensivists and infectious diseases consultants facing antimicrobial resistance: a global cross-sectional survey
  47. Extrapulmonary Tuberculosis
  48. National approaches to the vaccination of recently arrived migrants in Europe: A comparative policy analysis across 32 European countries
  49. Predictors of unfavorable outcome in neurosyphilis: Multicenter ID-IRI Study
  50. Radiological data in microbiologically confirmed central nervous system tuberculosis
  51. Infection Control Bundles in Intensive Care: An International Cross-sectional survey in Low-Middle Income Countries
  52. Correction to: Prediction of unfavorable outcomes in cryptococcal meningitis: results of the multicenter infectious Diseases International Research Initiative (ID-IRI) cryptococcal meningitis study
  53. Prediction of unfavorable outcomes in cryptococcal meningitis: results of the multicenter Infectious Diseases International Research Initiative (ID-IRI) cryptococcal meningitis study
  54. Central nervous system infections in the absence of cerebrospinal fluid pleocytosis
  55. Managing atypical and typical herpetic central nervous system infections: results of a multinational study – Authors' reply
  56. Community acquired infections among refugees leading to Intensive Care Unit admissions in Turkey
  57. “Salvage treatment” for infections by extensively- and pan-drug-resistant pathogens is common and often sub-optimal
  58. The burden and epidemiology of community-acquired central nervous system infections: a multinational study
  59. Tetanus in adults: results of the multicenter ID-IRI study
  60. Risk factors for infection development after transrectal prostate biopsy and the role of resistant bacteria in colonic flora
  61. Brucellosis
  62. Other Foci of Infections in Community Acquired Central Nervous System Infections
  63. Quality of life and related factors among chronic hepatitis B-infected patients: a multi-center study, Turkey
  64. Preface
  65. Mean platelet volume and red cell distribution width to platelet ratio for predicting the severity of hepatic fibrosis in patients with chronic hepatitis C
  66. Managing atypical and typical herpetic central nervous system infections: results of a multinational study
  67. Cranial imaging findings in neurobrucellosis: results of Istanbul-3 study
  68. Infections in travellers returning to Turkey from the Arabian peninsula: a retrospective cross-sectional multicenter study
  69. Management of septic shock and severe infections in migrants and returning travelers requiring critical care
  70. A Rare Case of Brucella Spondylodiscitis Mimicking Lumbar Disc Herniation
  71. Distribution of Tuberculomas and Vasculitic Lesions in Microbiologically Confirmed Central Nervous System Tuberculosis
  72. Hydrocephalus and vasculitis delay therapeutic responses in tuberculous meninigitis: Results of Haydarpasa-III study
  73. Neurosyphilis: Results of a Multicentric Infectious Diseases International Research Initiative (ID-IRI) Study
  74. Assessment of Health-Related Quality of Life in Chronic Hepatitis B Infection Patients in Turkey: A Multicenter Study
  75. Comparison of brucellar and tuberculous spondylodiscitis patients: results of the multicenter “Backbone-1 Study”
  76. Antituberculosis drug resistance patterns in adults with tuberculous meningitis: results of haydarpasa-iv study
  77. The course of spinal tuberculosis (Pott disease): results of the multinational, multicentre Backbone-2 study
  78. Paradoxes in Novel Hepatitis C Therapies: Is Combination of Sofosbuvir and Ribavirin Without Interferon Effective in Genotype 1b Chronic HCV Patients?
  79. New global viral threats
  80. Results of a Multinational Study Suggest the Need for Rapid Diagnosis and Early Antiviral Treatment at the Onset of Herpetic Meningoencephalitis
  81. Tuberculous and brucellosis meningitis differential diagnosis
  82. Hamsi scoring in the prediction of unfavorable outcomes from tuberculous meningitis: results of Haydarpasa-II study
  83. A Case of Pneumonia and Bacteriamia Caused by Corynebacterium Striatum in a Immun Supressed Host
  84. Imaging Data in Neurobrucellosis and the Factors Predicting Inflammatory Changes: Results of Istanbul-3 Study
  85. Evaluation of tularaemia courses: a multicentre study from Turkey
  86. Genitourinary brucellosis: results of a multicentric study
  87. The microbiological diagnosis of tuberculous meningitis of Haydarpasa-1 study
  88. International Nosocomial Infection Control Consortiu (INICC) report, data summary of 43 countries for 2007-2012. Device-associated module
  89. Clinical usefulness of mean platelet volume and red blood cell distribution width to platelet ratio for predicting the severity of hepatic fibrosis in chronic hepatitis B virus patients
  90. Nosocomial infection characteristics in a burn intensive care unit: Analysis of an eleven-year active surveillance
  91. Two Imported and Relapsed of Plasmodium vivax Malaria Cases and Primaquine Prophylaxis
  92. Comment to the Letter to the Editor
  93. The features of infectious diseases departments and anti-infective practices in France and Turkey: a cross-sectional study
  94. Emergence and co-infections of West Nile virus and Toscana virus in Eastern Thrace, Turkey
  95. Detection of Salmonella arizonae in an enteric fever outbreak by the ID 32 GN automated system
  96. The Management of Therapeutic Failure in a Falciparum Malaria Patient under Oral Arthemether-Lumefantrine Therapy
  97. Liver involvement in patients with brucellosis: results of the Marmara study
  98. Surveillance, control and management of infections in intensive care units in Southern Europe, Turkey and Iran – A prospective multicenter point prevalence study
  99. Mortality indicators in pneumococcal meningitis: therapeutic implications
  100. Update on treatment options for spinal brucellosis
  101. Respiratory System Involvement in Brucellosis
  102. The interrelations of radiologic findings and mechanical ventilation in community acquired pneumonia patients admitted to the intensive care unit: a multicentre retrospective study
  103. 1479Evaluation of Tularemia Courses: A Multicenter Study From Turkey
  104. 1160Compliance of rabies post exposure prophylaxis and rabies vaccine application problems
  105. 1477Factors affecting the early clinical response in due course of tuberculous meningitis treatment: Results of Haydarpasa-3 Study
  106. 1475Hamsi scoring in the prediction of unfavorable outcomes in tuberculous meningitis: Results of multinational Haydarpasa-2 Study
  107. Community-acquired pneumonia in patients with chronic obstructive pulmonary disease requiring admission to the intensive care unit: Risk factors for mortality
  108. Withdrawal of Staphylococcus aureus from intensive care units in Turkey
  109. Arboviral Surveillance of Field-Collected Mosquitoes Reveals Circulation of West Nile Virus Lineage 1 Strains in Eastern Thrace, Turkey
  110. Mortality indicators in community-acquired pneumonia requiring intensive care in Turkey
  111. Bronchoscopy as an indicator of tracheobronchial fungal infection in non-neutropenic intensive-care unit patients
  112. Diagnosis of chronic brucellar meningitis and meningoencephalitis: the results of the Istanbul-2 study
  113. Demonstration of mutations conferring resistance to lamivudine in liver tissue of chronic hepatitis B patients under lamivudine therapy
  114. Leading infectious diseases problems in Turkey
  115. Can chitotriosidase be a surrogate marker for invasive fungal disease?
  116. Management of Brucella endocarditis: results of the Gulhane study
  117. Basic answers to complicated questions for the course of chronic hepatitis C treatment
  118. Can chitotriosidase be a surrogate marker for invasive fungal disease?
  119. The Place and the Efficacy of Infectious Disease Consultations in the Hospitals
  120. Efficacy and Tolerability of Antibiotic Combinations in Neurobrucellosis: Results of the Istanbul Study
  121. War and infection in the pre-antibiotic era: The Third Ottoman Army in 1915
  122. Assessment of the requisites of microbiology based infectious disease training under the pressure of consultation needs
  123. Management of community-acquired acute bacterial cystitis in Turkey
  124. Community-acquired acute bacterial meningitis in the elderly in Turkey
  125. Overview of neurobrucellosis: a pooled analysis of 187 cases
  126. Stress-related Epstein–Barr virus reactivation
  127. Pneumococcal seroepidemiology in Turkey
  128. An Update on Invasive Pneumococcal Antibiotic Resistance in Turkey, 2008
  129. Meningoencephalitis associated with human parvovirus B19
  130. Changes in hepatitis A prevalence rates between 1998 and 2007 in Eskisehir, Turkey
  131. Prevalence of HIV and Syphilis among Turkish Blood Donors
  132. Erratum to “Pneumococcal seroepidemiology in Turkey: Implications for vaccine coverage” [Vaccine 26 (10) (2008) 1271–1273]
  133. Pneumococcal seroepidemiology in Turkey: Implications for vaccine coverage
  134. Prevalence of HIV and syphilis among Turkish blood donors
  135. Management of Neurobrucellosis: An Assessment of 11 Cases
  136. Management of Neurobrucellosis: An Assessment of 11 Cases
  137. The spectrum of diseases causing fever of unknown origin in Turkey: a multicenter study
  138. Hydatid cysts in muscle: a modified percutaneous treatment approach
  139. The Usefulness of Endoscopic Retrograde Cholangiopancreatography and 99mTc-Labeled Albumin Macroaggregates in Diagnosing Hydatid Disease Fistulae
  140. A review of the current place of glycopeptides in turkish medical practice
  141. Distribution of hepatitis C virus infection in the male Turkish population
  142. Delayed and misdiagnosis of wrist tuberculosis
  143. Epidemiology of corynebacterial urinary infections
  144. The Effects of Topical Ketorolac and Indomethacin on Measles Conjunctivitis: Randomized Controlled Trial
  145. Antimicrobial therapy in pneumococcal meningitis: an epidemiological assessment from Turkey
  146. Giardiasis in Sivas, Turkey
  147. Saccharomyces boulardiiand infection due toGiardia lamblia
  148. Profiles of biochemical parameters in central nervous system fluid during the therapeutic courses of adult Mycobacterium tuberculosis meningitis
  149. A New Percutaneous Approach for the Treatment of Hydatid Cyst of the Kidney: Long-term Follow-up
  150. Effect of Climate on the Bacteriology of Chronic Suppurative Otitis Media
  151. Treatment of Brucella Endocarditis: Our Surgical Experience with 6 Patients
  152. Prevalence of hepatitis B virus infection in young Turkish men
  153. Therapeutic options for pneumococcal pneumonia in Turkey
  154. Antibiotic Resistance in PathogenicStreptococcus pneumoniaeIsolates in Turkey
  155. Gram-Negative Bacterial Resistance to Cephalosporins in Community-Acquired Infections in Turkey
  156. Bacteriology in Patients with Chronic Sinusitis who have been Medically and Surgically Treated
  157. Identification of yeasts in public hospital primary care patients with or without clinical vaginitis
  158. An Unusual Cause of Vertebral Osteomyelitis: Candida Species